Single-dose versus 3-day prophylaxis with ciprofloxacin in transurethral surgery. A clinical trial.
In 235 patients who underwent transurethral surgery, perioperative oral ciprofloxacin prophylaxis was given as a single dose 500 mg versus a 3-day regimen. Out of 180 evaluable patients, 84 received a single dose and 96 received a 3-day course. In the single dose prophylaxis group there were 5 failures and in the 3-day prophylaxis group there were 6 failures. The difference is not significant. In 17 patients whose urine culture preoperatively yielded microorganisms the 3-day prophylaxis significantly eradicated the bacteriuria in 83% of the patients.